TELA Bio, Inc : NHS Surgeon First in Europe to Implant TELA Bio s OviTex LPR Reinforced Tissue Matrix finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs
May 25, 2021 07:00 ET | Source: TELA Bio, Inc. TELA Bio, Inc. Malvern, Pennsylvania, UNITED STATES
MALVERN, Pa., May 25, 2021 (GLOBE NEWSWIRE) TELA Bio, Inc. ( TELA ), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced the appointment of Marissa Conrad as the company s Vice President of Clinical and Regulatory Affairs effective May 24, 2021. As Vice President of Clinical and Regulatory Affairs, Marissa will establish and execute the clinical and regulatory strategy for TELA Bio s current products and future product pipeline.